Creative Medical Technology (CELZ) Competitors $1.96 -0.02 (-1.01%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELZ vs. TNYA, ITRM, COEP, LVTX, NLTX, BLUE, FBLG, DYAI, KZR, and MRNSShould you be buying Creative Medical Technology stock or one of its competitors? The main competitors of Creative Medical Technology include Tenaya Therapeutics (TNYA), Iterum Therapeutics (ITRM), Coeptis Therapeutics (COEP), LAVA Therapeutics (LVTX), Neoleukin Therapeutics (NLTX), bluebird bio (BLUE), FibroBiologics (FBLG), Dyadic International (DYAI), Kezar Life Sciences (KZR), and Marinus Pharmaceuticals (MRNS). These companies are all part of the "pharmaceutical products" industry. Creative Medical Technology vs. Tenaya Therapeutics Iterum Therapeutics Coeptis Therapeutics LAVA Therapeutics Neoleukin Therapeutics bluebird bio FibroBiologics Dyadic International Kezar Life Sciences Marinus Pharmaceuticals Tenaya Therapeutics (NASDAQ:TNYA) and Creative Medical Technology (NASDAQ:CELZ) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, media sentiment, risk, valuation, community ranking, dividends and earnings. Do analysts prefer TNYA or CELZ? Tenaya Therapeutics currently has a consensus target price of $6.25, suggesting a potential upside of 1,336.78%. Given Tenaya Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Tenaya Therapeutics is more favorable than Creative Medical Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tenaya Therapeutics 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Creative Medical Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor TNYA or CELZ? In the previous week, Tenaya Therapeutics had 6 more articles in the media than Creative Medical Technology. MarketBeat recorded 6 mentions for Tenaya Therapeutics and 0 mentions for Creative Medical Technology. Creative Medical Technology's average media sentiment score of 0.00 beat Tenaya Therapeutics' score of -0.17 indicating that Creative Medical Technology is being referred to more favorably in the news media. Company Overall Sentiment Tenaya Therapeutics Neutral Creative Medical Technology Neutral Which has more risk & volatility, TNYA or CELZ? Tenaya Therapeutics has a beta of 2.99, meaning that its stock price is 199% more volatile than the S&P 500. Comparatively, Creative Medical Technology has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500. Which has higher valuation & earnings, TNYA or CELZ? Creative Medical Technology has higher revenue and earnings than Tenaya Therapeutics. Creative Medical Technology is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTenaya TherapeuticsN/AN/A-$124.08M-$1.16-0.38Creative Medical Technology$14K371.28-$5.29M-$3.81-0.53 Is TNYA or CELZ more profitable? Creative Medical Technology's return on equity of -63.05% beat Tenaya Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Tenaya TherapeuticsN/A -86.17% -71.14% Creative Medical Technology N/A -63.05%-60.42% Do institutionals & insiders hold more shares of TNYA or CELZ? 90.5% of Tenaya Therapeutics shares are held by institutional investors. Comparatively, 1.4% of Creative Medical Technology shares are held by institutional investors. 32.8% of Tenaya Therapeutics shares are held by company insiders. Comparatively, 2.8% of Creative Medical Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer TNYA or CELZ? Creative Medical Technology received 27 more outperform votes than Tenaya Therapeutics when rated by MarketBeat users. However, 84.62% of users gave Tenaya Therapeutics an outperform vote while only 68.93% of users gave Creative Medical Technology an outperform vote. CompanyUnderperformOutperformTenaya TherapeuticsOutperform Votes4484.62% Underperform Votes815.38%Creative Medical TechnologyOutperform Votes7168.93% Underperform Votes3231.07% SummaryTenaya Therapeutics beats Creative Medical Technology on 10 of the 16 factors compared between the two stocks. Get Creative Medical Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for CELZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELZ vs. The Competition Export to ExcelMetricCreative Medical TechnologyBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.08M$2.93B$5.38B$8.39BDividend YieldN/A1.71%5.21%4.10%P/E Ratio-0.5330.5026.7619.71Price / Sales371.28400.15389.71117.54Price / CashN/A168.6838.2534.62Price / Book0.273.286.784.50Net Income-$5.29M-$72.17M$3.23B$248.18M7 Day Performance-0.50%2.96%1.51%0.23%1 Month Performance-0.50%3.25%10.03%12.39%1 Year Performance-53.47%-28.29%16.65%7.07% Creative Medical Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELZCreative Medical TechnologyN/A$1.96-1.0%N/A-55.0%$5.06M$14,000.00-0.515TNYATenaya Therapeutics3.442 of 5 stars$0.39-4.1%$6.25+1,484.7%-89.4%$34.54MN/A-0.27110ITRMIterum Therapeutics2.2472 of 5 stars$0.94-7.1%$9.00+859.1%-35.0%$33.49MN/A-0.7210COEPCoeptis Therapeutics0.718 of 5 stars$9.85-0.5%N/A+45.5%$33.15MN/A-1.702Positive NewsAnalyst UpgradeGap UpLVTXLAVA Therapeutics2.216 of 5 stars$1.25-2.3%$3.17+153.3%-50.2%$32.88M$11.98M-1.2160Analyst RevisionNLTXNeoleukin TherapeuticsN/A$17.70+20.2%N/A-45.5%$32.80MN/A-5.6990Gap UpHigh Trading VolumeBLUEbluebird bio2.7059 of 5 stars$3.31+0.6%$44.60+1,247.4%-75.1%$32.41M$83.81M-0.09520FBLGFibroBiologics1.5708 of 5 stars$0.84-3.4%$13.00+1,447.6%-91.7%$32.14MN/A-2.4710DYAIDyadic International2.2857 of 5 stars$1.06-3.6%$6.00+466.0%-38.3%$31.90M$3.50M-4.617KZRKezar Life Sciences4.1523 of 5 stars$4.20-0.7%$39.50+840.5%-48.3%$30.69M$7M-0.3260Gap UpMRNSMarinus Pharmaceuticals1.8807 of 5 stars$0.55-0.2%$4.79+771.6%-58.7%$30.32M$30.99M-0.22110News CoverageAnalyst Forecast Related Companies and Tools Related Companies Tenaya Therapeutics Alternatives Iterum Therapeutics Alternatives Coeptis Therapeutics Alternatives LAVA Therapeutics Alternatives Neoleukin Therapeutics Alternatives bluebird bio Alternatives FibroBiologics Alternatives Dyadic International Alternatives Kezar Life Sciences Alternatives Marinus Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELZ) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Creative Medical Technology Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Creative Medical Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CELZ Stock Free CELZ Stock Alerts